McCulloch, K., Litherland, G
[33] In chronic inflammatory bowel diseases, including Crohns disease, systematic reviews (including Cochrane reviews) have concluded that current randomized evidence is insufficient to support glutamine supplementation for inducing remission or modifying disease progression, and further well-powered clinical trials are required
Eguia RT, Crawford K, Stevens-Ayers T, Kelnhofer-Millevolte L, Greninger AL, Englund JA, et al
People using the drug were four times more likely to experience severe gastrointestinal reactions such as gastroparesis and intestinal blockages
In addition, the main HUVEC concentration experiments used BPC-157 in the microgram-per-milliliter range, whereas the alanine-mutant functional experiment was reported at 10 ng/mL